
APGE Stock Price Prediction
Apogee Therapeutics Inc
1-Day-Price-Prediction
+1.28%
1-Week Prediction
+2.31%
Based on our advanced algorithm, we predict that APGE stock price will experience significant movement in the coming periods. Our 1-day prediction estimates a price of $55.795, while the 1-week outlook suggests a value of $56.456. For the 1-month forecast, we project a price of $57.822. Looking further ahead, our 2026 projection estimates a value of $35.08, with a long-term 2030 forecast reaching $47.99. Stay informed and make strategic decisions with our data-driven insights!
57.822
Should I Buy Apogee Therapeutics Inc Stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. APGE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.
APGE stock price ended at $54.995 on Thursday, after losing -0.82%
The Apogee Therapeutics Inc stock price decreased by -0.82% on the last trading day (06 Nov 2025), dropping from 54.85 to 54.995. Throughout the last trading session, the stock experienced a fluctuation of 4.42% , ranging from a day low of $53.6301 to a day high of 56. The price has declined in 5 of the last 10 days, resulting in a total change of 2.18% during this period. On the last day, trading volume decrease by -361.82K shares, with the falling prices. This could serve as an early warning, indicating that risk may slightly increase in the coming days. In total, 680.43K shares were traded, amounting to approximately 37.06M.
APGE Technical Signals
APGE(Apogee Therapeutics Inc Corp) has 4 buy signals and 3 sell signals now. The current trend is an uptrend starting from 2025-09-22. The total price change during this trend is +44.88%. Recently, the price has dropped while volume droped, indicating a potential rebound signal. The average turnover of APGE over the last 5 trading days is 38.34M. Overall, the technical indicator signals lean more toward a Neutral outlook in the mid-term.
APGE Moving Average Analysis
Apogee Therapeutics Inc's overall moving average trend leans more bullish as of Thursday, November 6, 2025, with 1 negative signals and 3 positive signal. In the mid-term, the SMA_20 being above the SMA_60 signals a strong bullish trend. There will be some resistance from the lines at $58.93, and $61.07. A break-up above any of these levels will issue buy signals. There will be some support from the lines at $52.01, and $49.87. A break-down below any of these levels will issue sell signals.
APGE Short Selling Analysis
The short sale ratio of Apogee Therapeutics Inc(APGE) as of 04 Nov 2025 is 29.57%, rising from last trading day. With increasing price from 54.35 to 53.90. The short sell activity indicate that short sellers may be anticipating further declines.
Technical Signal
Technical Signals Summary

Neutral
Sell
3
Buy
4
Moving Average
Swing
Stock Price Below SMA_5
Short Term
SMA_5 Above SMA_20
Mid Term
SMA_20 Above SMA_60
Long Term
SMA_60 Above SMA_200
Short Selling
Close Price
Short Sale Ratio
Short Sale Volume
4 Bullish Signals
When Value satisfies Signal, Indicator signals Bullish
Indicators
Signal
Value
Meaning
Awesome Oscillator (5, 34)
AO_5_34 > 0
6.381
Bullish
Momentum (10 days)
MOM_10 > 0
1.175
Bullish
Moving Average Convergence Divergence (12, 26, 9)
MACD_12_26_9 > 0
2.819
Bullish
Stochastic RSI %K (14, 14, 3, 3)
STOCHRSIk_14_14_3_3 < 20
10.317
Bullish
3 Bearish Signals
When Value satisfies Signal, Indicator signals Bearish
Indicators
Signal
Value
Meaning
Moving Average
Price crosses below 5-day SMA
--
Bearish
Moving Average
Price crosses below 10-day SMA
--
Bearish
Moving Average
5-day SMA crosses below 10-day SMA
--
Bearish
APGE Stock Forecast
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
In 2026, Apogee Therapeutics Inc (APGE) is anticipated to change hands in a trading channel between $26.97 and $56.28.
Apogee Therapeutics Inc Stock Forecast 2026
Jan 2026: APGE Stock Forecast
Potential ROI: 20.75%
In Jan 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $47.47. The price is predicted to fluctuate between a low of $39.53 and a high of $55.87.
Feb 2026: APGE Stock Forecast
Potential ROI: 20.75%
In Feb 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $47.47. The price is predicted to fluctuate between a low of $42.31 and a high of $56.28.
Mar 2026: APGE Stock Forecast
Potential ROI: 20.75%
In Mar 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $47.47. The price is predicted to fluctuate between a low of $44.02 and a high of $52.81.
Apr 2026: APGE Stock Forecast
Potential ROI: 20.75%
In Apr 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $47.47. The price is predicted to fluctuate between a low of $38.51 and a high of $54.62.
May 2026: APGE Stock Forecast
Potential ROI: 15.25%
In May 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $45.30. The price is predicted to fluctuate between a low of $39.26 and a high of $45.41.
Jun 2026: APGE Stock Forecast
Potential ROI: 16.72%
In Jun 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $45.88. The price is predicted to fluctuate between a low of $43.86 and a high of $49.43.
Jul 2026: APGE Stock Forecast
Potential ROI: 2.01%
In Jul 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $40.10. The price is predicted to fluctuate between a low of $36.15 and a high of $46.02.
Aug 2026: APGE Stock Forecast
Potential ROI: -8.21%
In Aug 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $36.08. The price is predicted to fluctuate between a low of $27.57 and a high of $40.73.
Sep 2026: APGE Stock Forecast
Potential ROI: -10.75%
In Sep 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $35.08. The price is predicted to fluctuate between a low of $28.73 and a high of $38.50.
Oct 2026: APGE Stock Forecast
Potential ROI: 9.77%
In Oct 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $43.15. The price is predicted to fluctuate between a low of $35.91 and a high of $43.56.
Nov 2026: APGE Stock Forecast
Potential ROI: -10.75%
In Nov 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $35.08. The price is predicted to fluctuate between a low of $26.97 and a high of $38.09.
Dec 2026: APGE Stock Forecast
Potential ROI: 1.52%
In Dec 2026, Apogee Therapeutics Inc's value is forecasted to reach an average price of $39.91. The price is predicted to fluctuate between a low of $31.96 and a high of $44.90.
APGE Price Prediction & Forecast by Similar Chart Analysis
Based on historical patterns and backtesting of stocks with similar movements to Apogee Therapeutics Inc(APGE), our algorithm predicts APGE's 1-month price at $54.20, with an -4.23%downwardshift. Using a similarity score up to 99.18%and other factors, This forecast updates weekly, adjusting for significant deviations.
Similar Chart
The price prediction chart for Apogee Therapeutics Inc (APGE.O) stock, as of Sunday, November 2, 2025 , forecasts a -4.23% change over the next month, based on its high correlation with MCY.N stock patterns. The similarity between their price movements over the analyzed periods is 99.18%. The right panel lists other stocks with similar price patterns. This prediction is updated every week.

APGE
Future prediction
Up: -4.23%
Full Access. No Commitment.
7 Days Free!
AI Stock Picker
AI Swing Trade Signal
AI Earning Prediction
AI Screener
AI Financial Agent Help You Do Research
Already have an account? Sign In Here

MCY
Down: -4.23%Similarity: 99.18%
Name
Similarity
Up/Down

MCY.N
99.18%
-4.23%

HCA.N
99.06%
+1.57%

RH.N
99.03%
+31.66%

CCO.N
99.03%
-4.85%

PETS.O
99.02%
+13.06%

BRBS.A
99.01%
+7.39%

KMPR.N
99.00%
+3.44%

ATEC.O
98.98%
-4.11%

TPC.N
98.94%
+25.31%

NAVI.O
98.94%
-0.56%
APGE Seasonality Analysis
Based on APGE's historical stock price data across all years, the probability of a positive return in November is33.33%, suggesting it maynotbe an ideal month to invest in APGE. In contrast,Marchoffers the highest probability of positive returns at100.00%, making it a potentially strong month for investment.
However, this is only a prediction based on one method, and a comprehensive assessment of the stock's future trend should consider additional factors. Our final stock price commentary incorporates three main evaluation dimensions: technical signals, Moving Average trends, and similar chart pattern matching, with the first two dimensions carrying the primary weight to ensure a more robust and accurate forecast.
Monthly Seasonality
The radar chart shows that buying Apogee Therapeutics Inc (APGE.O) stock in March has the highest probability of a positive return (100.00%), while May has the lowest probability (0.00%).
Performance Seasonality
The chart shows Apogee Therapeutics Inc. (APGE)'s annual stock price return for the past three years, helping you analyze price trends and identify recurring trends on an annual basis.
People Also Watch

TRMK
Trustmark Corp
37.720
USD
-1.26%

IBRX
Immunitybio Inc
2.120
USD
-1.40%

PHIN
Phinia Inc
52.740
USD
-1.38%

PINC
Premier Inc
28.140
USD
-0.04%

SYBT
Stock Yards Bancorp Inc
66.170
USD
-1.05%

CCU
Compania Cervecerias Unidas SA
12.220
USD
-4.38%

KAR
Openlane Inc
24.940
USD
-4.30%

PLUS
ePlus inc
73.370
USD
-0.95%

PACS
Pacs Group Inc
12.480
USD
-2.80%

CMBT
CMB.TECH NV
9.250
USD
+1.65%
FAQ
Should I buy Apogee Therapeutics Inc (APGE.O) stock?
Based on our evaluation of the five key dimensions—Technical Signals, Moving Average trends, Short Sell Data, Similar Chart Pattern Matching and Seasonality Analysis—we have identified the following insights. APGE has several positive signals and is within a rising trend, so we believe it will perform strongly in the next couple of days or weeks. We therefore hold a positive evaluation of this stock. Our analysis conclusion for this stock is a Strong Buy candidate.





